http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#head http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#assertion http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#provenance http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#publicationInfo http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#assertion http://bio2rdf.org/drugbank:DB00359 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://bio2rdf.org/drugbank:DB01124 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://purl.org/dc/terms/identifier drugbank_resource:DB00359_DB01124 http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://purl.org/dc/terms/title DDI between Sulfadiazine and Tolbutamide - Tolbutamide and Sulfadiazine are strong CYP2C9 inhibitors and substrates. Decreased metabolism and clearance of both agents may occur during concomitant therapy. Consider alternate therpy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or dose(s) changed. http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00359_DB01124 http://www.w3.org/2000/01/rdf-schema#label DDI between Sulfadiazine and Tolbutamide - Tolbutamide and Sulfadiazine are strong CYP2C9 inhibitors and substrates. Decreased metabolism and clearance of both agents may occur during concomitant therapy. Consider alternate therpy or monitor for changes in the therapeutic and adverse effects of both agents if concomitant therapy is initiated, discontinued or dose(s) changed. [drugbank_resource:DB00359_DB01124] http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#provenance http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#publicationInfo http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#signature.MCwCFC0R2doY20NR http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#signature.MCwCFC0R2doY20NR http://purl.org/nanopub/x/hasSignature MCwCFC0R2doY20NRju7IaUU7IhIna/S7AhQStjwpBmxx697sKULoVk4PnoHYEA== http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#signature.MCwCFC0R2doY20NR http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://purl.org/dc/terms/created 2018-03-30T11:12:48.210+02:00 http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY#signature.MCwCFC0R2doY20NR http://bio2rdf.org/drugbank_resource:DB00359_DB01124_nanopub.RAyGGZX-AqCVISda9GQxpef-DppQAPa8KxVKS7ZsJh7JY http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234